Krystal Biotech Inc (KRYS) — Capital Reinvestment Ratio
Krystal Biotech Inc (KRYS) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow ($80.38 Million) in capital expenditures ($7.15 Million). See KRYS equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Krystal Biotech Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Krystal Biotech Inc's Capital Reinvestment Ratio across 2 annual periods. Check Krystal Biotech Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Krystal Biotech Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Krystal Biotech Inc from 2024 to 2025. For live market cap and broader valuation context, see KRYS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $200.87 Million | $11.95 Million | ▲ +73.3% |
| 2024 | 0.03x | $123.42 Million | $4.24 Million | — |